Noninferiority Testing
Noninferiority Testing is a statistical hypothesis testing framework used to determine whether a new intervention is not worse than an existing standard by more than a pre-specified margin, typically in clinical trials where demonstrating equivalence or acceptable loss of efficacy is the goal.
522
Publications
46K
Citations
4.8K
Authors
1.9K
Institutions
Publications per year
2017–2026
230
Parents
522
Jim Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 864 citations · Full text
Medicine, Oncology, Pharmacology +14
Leonardo Kapural, Cong Yu, Matthew W. Doust et al. · Anesthesiology · 2015 · 829 citations · Full text
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · New England Journal of Medicine · 2007 · 763 citations · Full text
1–5 of 522
4.8K
6
h-index
5
h-index
5
h-index
5
h-index
4
h-index
1–5 of 4.8K
1.9K
Harvard University
Cambridge, United States
15 h-index
35 publications
2.9K citations

Brigham and Women's Hospital
Boston, United States
14 h-index
24 publications
3.3K citations

University of Toronto
Toronto, Canada
13 h-index
27 publications
8.5K citations

Johns Hopkins University
Baltimore, United States
13 h-index
53 publications
11.9K citations
University of California, San Francisco
San Francisco, United States
11 h-index
16 publications
1.2K citations
United States Food and Drug Administration
Silver Spring, United States
11 h-index
28 publications
1.9K citations
University of Pennsylvania
Philadelphia, United States
10 h-index
48 publications
2.2K citations
Emory University
Atlanta, United States
10 h-index
11 publications
1.1K citations
1–8 of 1.9K
NEJM · 22 publications · 8.2K citations
22
h-index
17 publications · 3K citations
16
h-index
15 publications · 5K citations
15
h-index
JBS · 18 publications · 497 citations
13
h-index
CID · 13 publications · 922 citations
12
h-index
1–5